Notes: Each vial contains 200 µg of lyophilized peptide derived from the human EP1 receptor sequence (C-terminal amino acids 380-402; GLTPSAWEASSLRSSRHSGLSHF.{3176} This peptide was used as an antigen for production of Cayman’s EP1 receptor polyclonal antibody (Catalog No. 101740) and can be used in conjunction with this antibody to block protein-antibody complex formation during analysis for the EP1 receptor.